Answers are grounded in this paper and cite their sources.
BACKGROUND: Little is known about the determinants of disease progression among African patients with chronic HBV infection. METHODS: We used machine-learning models with longitudinal data to establish predictive algorithms in a well-characterized cohort of Ethiopian HBV-infected patients without baseline liver fibrosis. Disease progression was defined as an increase in liver stiffness to >7.9 kPa or initiation of treatment based on meeting the eligibility criteria. RESULTS: Twenty-four of 551 patients (4.4%) experienced disease progression after a median follow-up time of 69 months. A random forest model based on a combination of available laboratory tests (standard hematology and biochemistry) demonstrated the best predictive properties with the AUROC ranging from 0.82 to 0.88. CONCLUSION: We conclude that combined metrics based on simple and available laboratory tests had good predictive properties and should be explored further in larger HBV cohorts.
No takes yet. Share an insight, caveat, or question.
Desalegn et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: